Novel Role of the Epstein-Barr Virus Encoded Deubiquitinating Enzyme (BPLF1) in mTOR-Mediated Cell Growth and Proliferation Pathways
Viruses · 2025
DOI: 10.3390/v17081139 ↗Kurz gefasst
Fachartikel in der Zeitschrift Viruses, 2025. Verfasst von Rachel Mund und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Microbiology and Immunology, New York Medical College, New York, NY 10595, USA. Hauptthemen laut MEDLINE: TOR Serine-Threonine Kinases, Herpesvirus 4, Human, Cell Proliferation, Deubiquitinating Enzymes. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, National Institute of Health, NYMC.
Abstract (Originalsprache)
Epstein-Barr Virus (EBV) is a causative agent of infectious mononucleosis and is strongly associated with Burkitt lymphoma, Hodgkin lymphoma, and nasopharyngeal carcinoma. EBV encodes a deubiquitinating enzyme, BPLF1, which is important for infectious virus production, B-cell immortalization, and tumorigenesis. To elucidate BPLF1’s role, an affinity-based mass spectrometry screen was performed, which suggested that BPLF1 and mTOR interact. mTOR, a critical mediator within cellular signaling cascades and oncogenesis, exists in two distinct complexes: mTOR Complex 1 (mTORC1) and mTOR Complex 2 (mTORC2). Here, we show that BPLF1 has direct deubiquitinating (DUB) activity on mTOR, removing both K48- and K63-ubiquitin linkages. Additionally, WT BPLF1 decreased mTORC1 localization to the lysosome and decreased the phosphorylation of mTORC1 downstream effectors, 4E-BP1 and S6K1. BPLF1 also had DUB activity on Raptor and Rictor, which have both been shown to preferentially cause the formation of mTORC2 over mTORC1 when not ubiquitinated. Immunoprecipitation of mTOR shows decreased mTORC1 formation in the presence of WT BPLF1. Importantly, treatment with rapamycin, an mTORC1 inhibitor, increased infectious virus production, while JR-AB2-011, an mTORC2 inhibitor, reduced infectious virus production. Taken together, these data demonstrate that BPLF1’s effect on the mTOR signaling cascade regulates cellular and viral processes during EBV infectivity and replication.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, Microbiology and Immunology, New York Medical College, New York, NY 10595, USA.
- Department of Microbiology and Immunology, University of North Carolina Chapel Hill, Chapel Hill, NC 27599, USA.
Förderung
- NIAID NIH HHS
- National Institute of Health
- NYMC
Zitieren
APA
Mund, R., Atkins, S. L., Cao, A., Diallo, A., & Whitehurst, C. B. (2025). Novel Role of the Epstein-Barr Virus Encoded Deubiquitinating Enzyme (BPLF1) in mTOR-Mediated Cell Growth and Proliferation Pathways. Viruses. https://doi.org/10.3390/v17081139
Vancouver
Mund R, Atkins SL, Cao A, Diallo A, Whitehurst CB. Novel Role of the Epstein-Barr Virus Encoded Deubiquitinating Enzyme (BPLF1) in mTOR-Mediated Cell Growth and Proliferation Pathways. Viruses. 2025. doi:10.3390/v17081139
BibTeX
@article{Mund2025,
author = {Mund, Rachel and Atkins, Sage L and Cao, Anwen and Diallo, Aminatou and Whitehurst, Christopher B},
title = {Novel Role of the Epstein-Barr Virus Encoded Deubiquitinating Enzyme (BPLF1) in mTOR-Mediated Cell Growth and Proliferation Pathways},
journal = {Viruses},
year = {2025},
doi = {10.3390/v17081139}
}
EUVIMED